Navigation Links
Novus Scientific Announces a New U.S. Patent for a Mesh Implant Comprising Two Different Resorbable Materials with Different Degradation Times and Specific Mechanical Behaviours; U.S. Patent No. -- 8,083,755
Date:12/27/2011

SINGAPORE, Dec. 27, 2011 /PRNewswire/ -- The Intellectual Property portfolio of TIGR® Matrix Surgical Mesh has been further complimented with the granting of a second U.S. patent related to material degradation and mechanical behaviour. TIGR® Matrix was developed based on the hypothesis that soft tissue positively remodels in response to the stimulus of increased mechanical load – a process known as 'mechanotransduction', which is the physiological process by which cells sense and respond to mechanical loads. This key feature contributes to the functional regenerated tissue that ultimately replaces the degraded mesh, as shown in preclinical trials. (ref:http://www.springerlink.com/content/c033k26015677312/).

The first U.S. patent covered the interlocking structure of a knitted mesh implant. The mechanotransductional function of TIGR® Matrix is now further protected.

Roger Johansson (Ph.D.) – Vice President Sweden said: "This is a step toward protecting the basic underlying technology behind TIGR® Matrix Surgical Mesh. To have it safely on file alongside our other U.S. and European patents increases our stake in the niche market of which we are sole initiator thus far, and represents real value to Novus Scientific and the future of TIGR® Matrix."

TIGR® Matrix Surgical Mesh is the World's 1st Long-Term Resorbable, (100% Absorbable) Synthetic Mesh indicated for reinforcement of soft tissue where weakness exists. Its unique patented dual-fiber construction is designed for gradually increasing mechanical compliance, making it strong for 6 months and gone in 3 years. The US Food and Drug Administration (FDA) gave the company 510(k) clearance to market TIGR® Matrix Surgical Mesh in February 2010. In August 2011 Novus Scientific received CE Mark approval from BSI for TIGR® Matrix Surgical Mesh in Europe.

TIGR® Matrix Surgical Mesh is available for sale in the U.S. and selected countries in Europe and Asia.

About Novus Scientific
Novus Scientific (www.novusscientific.com) is an innovator in the development and commercialization of resorbable synthetic medical devices.

For comprehensive information vist our PRESSROOM: http://www.mynewsdesk.com/pressroom/novus-scientific

TIGR® is a trademark of Novus Scientific Pte. Ltd

 

CONTACT:  
Roger Johansson: +46 (0)73 396 55 45-  roger.johansson@novusscientific.com

 

 


'/>"/>
SOURCE Novus Scientific
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Novus Scientific Receives FDA Clearance for TIGR(TM) Matrix Surgical Mesh - Worlds 1st Long-Term Resorbable Synthetic Mesh
2. Novus Scientific Announces the Sales Launch for TIGR™ Matrix Surgical Mesh - Worlds 1st Long-Term Resorbable Synthetic Mesh
3. Novus Scientific and Singapore Association of Plastic Surgeons (SAPS) Host the Inaugural Event of SOFTISSUE - The Issue of Soft Tissue, Featuring James J. Chao, M.D., FACS, Professor of Plastic Surgery and Orthopedic Surgery, University of Califor
4. Novus Scientific Announces the Worlds 1st Long-Term Absorbable Mesh as an Alternative to Non-Absorbable Synthetic Mesh
5. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
6. Avicena Scientific Collaborator Advances Program for Using Energy Enhancing Molecules to Treat Neuromuscular Diseases
7. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
8. Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007
9. Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) and Boston Scientifics Taxus(R) Stent in Patients at High Risk of Restenosis
10. Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
11. Boston Scientifics Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/15/2017)... 15, 2017 Diplomat Pharmacy, Inc. (NYSE: DPLO), ... Michigan residents. Naloxone is available ... retail pharmacy, G-3320 Beecher Road. ... and Drug Administration, is intended to block or reverse ... and loss of consciousness. The medication is often carried ...
(Date:8/14/2017)... N.J. and PETACH TIKVAH, Israel ... Inc. (NASDAQ: BCLI), a leading developer of adult stem ... the second quarter ending June 30, 2017. ... stages of preparing for our pivotal Phase 3 trial ... Chaim Lebovits , President and Chief Executive Officer of ...
(Date:8/8/2017)... Second-quarter 2017 revenues of $876 ... from continuing operations Second-quarter ... $110 million Second-quarter 2017 ... Second-quarter 2017 adjusted diluted ... percent to $0.93 Second-quarter ...
Breaking Medicine Technology:
(Date:8/23/2017)... (PRWEB) , ... August 23, 2017 , ... ... Therapy continues to prove the safety and efficacy of HBOT in treating and ... across the US, points to research showing the similarities of the wounds to ...
(Date:8/23/2017)... TX (PRWEB) , ... August 23, 2017 , ... ... in the healthcare industry, made the 2017 Inc. 5000 with a three-year ... of the nation’s fastest-growing private companies and comprises the most comprehensive look at ...
(Date:8/23/2017)... ... August 23, 2017 , ... MobilityWorks ®, ... named to the 2017 Inc. 500|5000, an exclusive ranking of America’s fastest-growing private ... of 139 percent, marking the twelfth year that the company has been included ...
(Date:8/23/2017)... ... 23, 2017 , ... A new literature review ... points out that therapeutic modalities (physical therapy) is an important part of the ... a wider scope of physical therapy options is showing promising results and supports ...
(Date:8/22/2017)... ... August 22, 2017 , ... The old adage ... as simple as eating healthy foods. But this well-known piece of nutrition advice ... or breaking apart carbohydrates—depends not only on properties of the food but also ...
Breaking Medicine News(10 mins):